High materiality7/10
AbbVie price target raised to $260 from $230 at UBS
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises ABBV target to $260 from $230; current price $247.05; upside potential remains to target.
- Target: $260 (from $230)
- Price: $247.05
- Upside to target
Key facts
- 01
Target: $260
- 02
Posted price: $247.05
- 03
Analyst firm: UBS
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.